Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms

The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines produced their first edition in 1999, with subsequent revisions in 2008, 2010, 2016 and 2019. A new iteration of ARIA-ARIA 2024-2025-in collaboration with EAACI is currently being developed, focusing on the management of allergic rhinitis. ARIA 2024-2025 follows the GRADE framework and is endorsed by the European Academy of Allergy and Clinical Immunology (EAACI). A set of approaches has been used to develop guideline questions, including surveying key opinion leaders and using artificial intelligence (AI)-based tools to analyse web searches on allergic rhinitis and to generate questions. Each prioritised guideline question is assessed through an Evidence-to-Decision (EtD) framework. EtDs support the systematic and transparent formulation of recommendations, comprising 12 criteria for which the best available evidence should be sought. In the context of ARIA-EAACI 2024-2025, such evidence is derived not only from randomised controlled trials but also-among others-from patient-generated data sources that better reflect the affected individuals' perspectives. Moreover, ARIA-EAACI 2024-2025 incorporates evidence on planetary health. Developed guideline recommendations will support the creation of digitalised decision algorithms and care pathways. This paper describes the methodology used to develop the person-centred, digitally enabled and AI-assisted ARIA-EAACI 2024-2025. Among others, it describes (i) the development and prioritisation of guideline questions, (ii) sources of evidence for EtDs and (iii) the development of digitalised decision algorithms and care pathways.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-11-21
DOI
https://doi.org/10.1111/all.70100
Citations
3
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
4.87

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms

André Luiz da Costa Moreira, Giovanni Viegi, Nicolás Roche, Janet Mary Davies et al.
3 citations
Allergy
Allergic Rhinitis and Sensitization
4.87
article

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms

André Luiz da Costa Moreira, Giovanni Viegi, Nicolás Roche, Janet Mary Davies, M. Bourgoin‐Heck, Piotr Kuna, Ana Todo‐Bom, Leticia de las Vecillas, Yuliia Palamarchuk, Ana Margarida Pereira, Bolesław Samoliński, Nicola Scichilone, Torsten Zuberbier, Baharudin Abdullah, Robert M. Naclerio, Marianella Salapatas, Bilun Gemicioğlu, Marek Kulus, Padukudru Anand Mahesh, Ilgım Vardaloğlu, Maria Cristina Artesani, Tanja Soklič Košak, Olga Sozinova, Philip W. Rouadi, Isabella Pali‐Schöll, Marylin Valentin Rostan, Niels Henrik Chavannes, Maximiliano Gómez, Michael Soyka, Mattia Giovannini, Pongsakorn Tantilipikorn, Michael E. Hyland, Iván Chérrez-Ojeda, Sara Gil‐Mata, Tari Haahtela, Mário Morais‐Almeida, Miloš Jeseňák, D Larenas-Linnemann, А.И. Курченко, Antonio Francesco Maria Giuliano, Carla Irani, Yi‐Kui Xiang, Tuula Vasankari, Paulo Augusto Moreira Camargos, José Miguel Fuentes Pérez, Rafael José Vieira, Carlo Mario Lombardi, Ruby Pawankar, Maia Rukhadze, Stefania La Grutta, Despo Ierodiakonou, Michael P. Makris, Vesna Tomić-Spirić, Santiago Quirce, Radosław Gawlik, Luo Zhang, Hugo Neffen, Marine Savouré, Ignacio Javier Ansotegui, Roland Buhl, Bernardo Sousa‐Pinto, Philippe Devillier, Lorenzo Cecchi, Giorgio Walter Canonica, Elı́sio Costa, Juan Carlos Ivancevich, Krzysztof Specjalski, Jaime Correia de Sousa, Marilyn Urrutia‐Pereira, Alla Nakonechna, Óscar Palomares, Sven Becker, Zhanat Ispayeva, Robyn E. O’Hehir, Oliver Pfaar, Dieudonné T. Nyembue, Matteo Martini, Daiju Sakurai, Ігор Петрович Кайдашев, George Christoff, Lan Le Thi Tuyet, Victòria Cardona, Marek Niedoszytko, D. Charpin, Ludger Klimek, Jan Romantowski, Todor A. Popov, Martin Wagenmann, Pascal Werminghaus, Antonino Romano, Menachem Rottem, Martina Vachová, Helga Kraxner, Ioanna Tsiligianni, Francesca Puggioni, Jane da Silva, Vincenzo Patella, María Julia Calvo-Gil, Eris Mesonjësi, Vicky Kritikos, Luís Taborda‐Barata, Giorgio Ciprandi, Petr Panzner, Maia Gotua, Cemal Cingi, Milan Sova, Margitta Worm, Antonio Bognanni, Pedro Martins, Violeta Kvedarienė, Rita Amaral, María Susana Repka-Ramirez, Bruno Acatauassú Paes Barreto, Bianca Beghé, Manuel Marques‐Cruz, Herberto José Chong‐Neto, Heidi Olze, Arzu Yorgancıoğlu, Biljana Cvetkovski, Laila Salameh, Sophia Neisinger, Alessandro Fiocchi, Danilo Di Bona, Amir Hamzah Abdul Latiff, Gennaro D’Amato, Maryam Ali Al‐Nesf, Tuomas Jartti, Giovanni Rolla, Inger Kull, Tomohisa Iinuma, Fulvio Braido, Maciej Kupczyk, Elham Hossny, Branislava Milenković, Aspasia Karavelia, Dejan Dokic, Álvaro Augusto Cruz, Alkis Togias, Mohamed H. Shamji, Olga Lourenço, Marianne van Hage, Graham Roberts, Faradiba Serpa Sarquis, Josep M. Antó, Daniela Rivero‐Yeverino, Sandra Nora González Díaz, Rachel Nadif, İsmail Öğülür, Thomas B. Casale, Mona Sulaiman Al-Ahmad, Manuel E. Soto‐Martínez, Brigita Gradauskienė, N. Pham‐Thi, Holger J. Schünemann, Marysia Stella T. Recto, Marta Alina Kisiel, Stefano R. Del Giacco, Kaja Julge, Michał Ordak, Mihaela Zidarn, Enrico Compalati, Osman Mohammad Yusuf, Fanny W.S. Ko, Maria Dimou, Michael S. Blaiss, Marta Chełmińska, Karla Robles‐Velasco, Derek K. Chu, Éric Van Ganse, De Yun Wang, Maria Doulaptsi, Juan José Yepes-Núñez, Frederico S. Regateiro, Marcin Moniuszko, Maria Do Céu Teixeira, Constantinos Pitsios, Maria Teresa Ventura, Vladyslav Tsaryk, Jonathan A. Bernstein, Arūnas Valiulis, Neven Miculinić, João Fonseca, Lei Cheng, Özlem Göksel, Cem Meço, J. Sastre, Giovanni Paoletti, Mitja Košnik, Sang Min Lee, Marı́a José Torres, Nikolaos G. Papadopoulos, Anna Bedbrook, Dirceu Solé, José Antonio Castillo Vizuete, Nikolaï Khaltaev, Pakit Vichyanond, María Antonieta Guzmán, Charlotte Suppli Ulrik, Kazi Saifuddin Bennoor, Ineta Grisle, Cristina Jacomelli, Ieva Cirule, Erkka Valovirta, Agné Ramonaité, Sanna Toppila‐Salmi, Ken Ohta, Yousser Mohammad, Mikhail Sofiev, Mark S. Dykewicz, Karl-C Bergmann, Joaquim Mullol, Ekaterine Chkhartishvili, Bassam Mahboub, Juan Carlos Sisul, Emmanuel Prokopakis, Christos Grigoreas, F Mihălţan, Lucas Leemann, Luisa Brussino, Jacques Bouchard, Dana Wallace, Rachel Tan, Stephen Montefort, Sian Williams, D. Choudhury, Yoshitaka Okamoto, Vicky Paraskevi Xepapadaki, Edgar Arturo Perdomo‐Flores
article en
3 citations

Abstract

The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines produced their first edition in 1999, with subsequent revisions in 2008, 2010, 2016 and 2019. A new iteration of ARIA-ARIA 2024-2025-in collaboration with EAACI is currently being developed, focusing on the management of allergic rhinitis. ARIA 2024-2025 follows the GRADE framework and is endorsed by the European Academy of Allergy and Clinical Immunology (EAACI). A set of approaches has been used to develop guideline questions, including surveying key opinion leaders and using artificial intelligence (AI)-based tools to analyse web searches on allergic rhinitis and to generate questions. Each prioritised guideline question is assessed through an Evidence-to-Decision (EtD) framework. EtDs support the systematic and transparent formulation of recommendations, comprising 12 criteria for which the best available evidence should be sought. In the context of ARIA-EAACI 2024-2025, such evidence is derived not only from randomised controlled trials but also-among others-from patient-generated data sources that better reflect the affected individuals' perspectives. Moreover, ARIA-EAACI 2024-2025 incorporates evidence on planetary health. Developed guideline recommendations will support the creation of digitalised decision algorithms and care pathways. This paper describes the methodology used to develop the person-centred, digitally enabled and AI-assisted ARIA-EAACI 2024-2025. Among others, it describes (i) the development and prioritisation of guideline questions, (ii) sources of evidence for EtDs and (iii) the development of digitalised decision algorithms and care pathways.

AllergyVol. 81(2)
Semmelweis University (HU), Université Paris-Sud (FR), University of Foggia (IT), Latakia University (SY), Universidade Federal de Minas Gerais (BR), Tongji University (CN), Universidad Complutense de Madrid (ES), University of Modena and Reggio Emilia (IT), Marche Polytechnic University (IT), Uppsala University (SE), University of Copenhagen (DK), Universidade Federal da Bahia (BR), University of Medicine Tirana (AL), Finnish Meteorological Institute (FI), Beijing Tongren Hospital (CN), The University of Sydney (AU), Fundação de Amparo à Pesquisa do Estado da Bahia (BR), Lithuanian University of Health Sciences (LT), American College of Allergy, Asthma and Immunology (US), Siriraj Hospital (TH), Karolinska University Hospital (SE), University of Helsinki (FI), Humanitas University (IT), Universiti Sains Malaysia (MY), École Polytechnique (FR), University of Crete (GR), Johns Hopkins University (US), Medical University of Białystok (PL), University of Liverpool (GB), Ankara University (TR), University of Veterinary Medicine Vienna (AT), Imperial College Healthcare NHS Trust (GB), University of Ljubljana (SI), Inserm (FR), University of Turku (FI), Chiba University (JP), Queensland University of Technology (AU), Philipps University of Marburg (DE), University of Beira Interior (PT), Carol Davila University of Medicine and Pharmacy (RO), Universidad de Los Andes (CO), Turku University of Applied Sciences (FI), University of Applied Sciences Mainz (DE), Austral University of Chile (CL), National University of Singapore (SG), Medical University of Silesia (PL), Manisa Celal Bayar University (TR), Universidad Autónoma de Nuevo León (MX), Universitat Pompeu Fabra (ES), University of Cagliari (IT), Vilnius University (LT), University of Nicosia (CY), Technion – Israel Institute of Technology (IL), University of Eastern Finland (FI), Chinese University of Hong Kong (HK), Universidade do Porto (PT), Saint Joseph University (LB), Kazakh National Medical University (KZ), Université de Versailles Saint-Quentin-en-Yvelines (FR), Johannes Gutenberg University Mainz (DE), University of Malta (MT), National and Kapodistrian University of Athens (GR), University of Zurich (CH), Nova Southeastern University (US), Université Paris Cité (FR), Cornell University (US), Charles University (CZ), Augusta University (US), University of Cape Verde (CV), Mahidol University (TH), University of South Florida (US), Medical University of Warsaw (PL), Université Paris-Saclay (FR), Paracelsus Medical University (AT), Emek Medical Center (IL), Santa Maria Nuova Hospital (IT), Hospital Kuala Lumpur (MY), Johns Hopkins Medicine (US), Rafik Hariri University Hospital (LB), Leiden University Medical Center (NL), Amersham Hospital (GB), Helsinki University Hospital (FI), Mother Teresa Hospital (AL), Rashid Hospital (AE), Woolcock Institute of Medical Research (AU), Instituto de Salud Carlos III (ES), American Academy of Allergy, Asthma and Immunology (US), Hvidovre Hospital (DK), Turku University Hospital (FI), Hospitais da Universidade de Coimbra (PT), Hellenic Air Force (GR), Philippine General Hospital (PH), Tartu University Hospital (EE), Hospital Center of Cova da Beira (PT), Kinshasa General Hospital (CD), Copenhagen University Hospital (DK), University Hospital Southampton NHS Foundation Trust (GB), Karolinska Institutet (SE), University of Sharjah (AE), Medical University of Sofia (BG), Hospital de São João (PT), Agostinho Neto University (AO), Universidad Espíritu Santo (EC), Universidad de Costa Rica (CR), University of Cyprus (CY), University of Kinshasa (CD), Kuwait University (KW), Humboldt-Universität zu Berlin (DE), Sorbonne Université (FR), University of Belgrade (RS), Universidade Federal de Santa Catarina (BR), Ege University (TR), Hôpital Armand-Trousseau (FR), Ontario Clinical Oncology Group (CA), Centro Científico Tecnológico - Santa Fe (AR), Vilnius University of Applied Sciences (LT), University Geomedi (GE), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), Düsseldorf University Hospital (DE), Hôpital de la Croix-Rousse (FR), Hospital Universiti Sains Malaysia (MY), Metro South Health (AU), Oasi Maria SS (IT), Sorbonne Paris Cité (FR), Hamilton Utilities Corporation (CA), Hôpital Cochin (FR), Monash Alfred Psychiatry Research centre (AU), Allergy, Asthma and Clinical Research Center (US), Stockholm South General Hospital (SE), Ain Shams University Hospital (EG), Hospital Universitario Dexeus (ES), Assistance Publique – Hôpitaux de Paris (FR), Technologies pour la Santé (FR), Riga East University Hospital (LV), Chiba University Hospital (JP), Atlanta Allergy and Asthma Clinic (US), University Hospital of Zurich (CH), Centro Universitário do Pará (BR), University Medical Center HCMC (VN), University Hospital Brno (CZ), University Clinic of Traumatology (AT), Hospital Médica Sur (MX), Hospital La Paz Institute for Health Research (ES), University Hospital St. Ivan Rilski (BG), Centre de recherche en Epidémiologie et Santé des Populations (FR), Clinical Research Center for Hair and Skin Science (DE), Istituto di Fisiologia Clinica (IT), Center for Health, Exercise and Sport Sciences (RS), Poltava State Agrarian University (UA), Fraunhofer Institute for Translational Medicine and Pharmacology (DE), Mohammed Bin Rashid University of Medicine and Health Sciences (AE), Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie (DE), Finnish Lung Health Association (FI), Fatebenefratelli Hospital (IT), Hospital Regional Universitario de Málaga (ES), Casa di Cura Villa Garda (IT), Azienda Ospedaliero-Universitaria di Modena (IT), NIHR Imperial Biomedical Research Centre (GB), Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (BR), Universidad Católica de Salta (AR), Centar za Promociju Nauke (RS), Istanbul University-Cerrahpaşa (TR), CUF Porto Hospital (PT), Institute for Asthma and Allergy (US), Meyer Children's Hospital (IT), University Clinic of Pulmonary and Allergic Diseases Golnik (SI), Hospital Quirónsalud Barcelona (ES), General Hospital of Drama (GR), Virologie et Immunologie Moléculaires (FR), Hôpital Nord (FR), Centro de Investigación Biomédica en Red (ES), Hospital Clínic de Barcelona (ES), Syrian Private University (SY), Hospital de Dona Estefânia (PT), Children's Clinical University Hospital (LV), Casa di Cura Columbus (IT), Institute for Symbolic analysis and Development of Information Technologies (SI), MSD (Mexico) (MX), NIHR Southampton Biomedical Research Centre (GB), AIDS and Clinical Immunology Research Center (GE), Guyra Paraguay (PY), Zentrum für Rhinologie und Allergologie (DE), Laboratoire d'études sur les monothéismes (FR), Monash Health (AU), Care International (CH), Medical University of Lodz (PL), Bambino Gesù Children's Hospital (IT), Institutul de Pneumoftiziologie "Marius Nasta" (RO), Hospital San Juan de Dios (CL), Public Health Agency (GB), Polydoro Ernani de São Thiago University Hospital (BR), Vall d'Hebron Hospital Universitari (ES), Sachs' Children and Youth Hospital (SE), Institut de Médecine Tropicale du Service de Santé des Armées (FR), A. O. Ordine Mauriziano di Torino (IT), Hospital Universitario Fundación Jiménez Díaz (ES), NCCR Chemical Biology - Visualisation and Control of Biological Processes Using Chemistry (CH), Institute for Biomedical Research and Innovation (IT), Hospital Clínico de la Universidad de Chile (CL), Institute of Sciences of Food Production (IT), Fundación Santa Fe de Bogotá (CO), St Mary's Hospital (GB), USP Institut Universitari Dexeus (ES), Istituto di Farmacologia Traslazionale (IT), CNR de la Résistance aux Antibiotiques (FR), Bernstein Center for Computational Neuroscience Tübingen (DE), National Institute of Allergy and Infectious Diseases (US), Lofarma (Italy) (IT), Allergy Asthma Research Institute (US), Hospital Nacional de Niños (CR), Institut Hospitalier Franco Britannique (FR), Centre for Health Technology and Services Research (PT), David Tvildiani Medical University (GE), David Hide Asthma and Allergy Research Centre (GB), Instituto Universitario Puebla (MX), Laboratoire d'Informatique de l'École Polytechnique (FR), University General Hospital Attikon (GR), Institut Cochin (FR), Alloheim (Germany) (DE), Pulmonary Associates (US), Asthma Association (BG), Croatian Science Foundation (HR), PHI University Psychiatric Clinic - Skopje (MK), Ospedale Policlinico San Martino (IT), Fondazione Poliambulanza Istituto Ospedaliero (IT), Barcelona Institute for Global Health (ES), National Institute of Cardiovascular Diseases (BD), Fukujuji Hospital (JP), Hôtel-Dieu de France (LB), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Chiba Rosai Hospital (JP), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), National Research Council (IT), Shanghai Skin Disease Hospital (CN), Azienda Usl Toscana Centro (IT), Hôpital Foch (FR), Sogei (Italy) (IT), Republic Klaipeda Hospital (LT), i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT), Impact (CA), Clínica Ruiz (MX), IRCCS Humanitas Research Hospital (IT), Alfred Health (AU), Dermatology Research Center (US), Martin University Hospital (SK), Czech Academy of Sciences, Institute of Physiology (CZ), St. Mary's Hospital (GB), Université Laval (CA), University of Southampton (GB), Centre de Recherche Épidémiologie et Statistique (FR), Poltava State Medical University (UA), Research on healthcare performance (FR), Heinrich Heine University Düsseldorf (DE), University of Florence (IT), Saint Louis University (US), Hamad Medical Corporation (QA), Eskişehir Osmangazi University (TR), Universidade Federal do Paraná (BR), University of Turin (IT), University of Bari Aldo Moro (IT), University of Tartu (EE), Monash University (AU), University of the Philippines Manila (PH), Universidad Autónoma de Madrid (ES), University of Yamanashi (JP), University of Chile (CL), University of Naples Federico II (IT), Universitat de Barcelona (ES), Universidade Federal do Pampa (BR), Comenius University Bratislava (SK), Gdańsk Medical University (PL), Freie Universität Berlin (DE), University of Coimbra (PT), Charité - Universitätsmedizin Berlin (DE), Nippon Medical School (JP), University of Tübingen (DE), Universidad de Málaga (ES), Nanjing Medical University (CN), Universidade Nova de Lisboa (PT), Universidad Nacional de Asunción (PY), University of Genoa (IT), Polytechnic Institute of Porto (PT), Bogomolets National Medical University (UA), University of Silesia in Katowice (PL), JSS Medical College and Hospital (IN), Damascus University (SY), Universidade Federal de São Paulo (BR), Chartered Institute of Management Accountants (GB), Dankook University (KR), University of Plymouth (GB), University of Palermo (IT), University of Latvia (LV), University of Cincinnati Medical Center (US), McMaster University (CA), Macquarie University (AU), University of Minho (PT)
Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche, Università degli Studi di Napoli Federico II, Université Laval, University of South Florida, McMaster University, Regeneron Pharmaceuticals, Università degli Studi di Cagliari, Covis Pharma, Ospedale Pediatrico Bambino Gesù, European Commission, Institut National de la Santé et de la Recherche Médicale, Universiteit Leiden, Queensland University of Technology, Semmelweis Egyetem, Eberhard Karls Universität Tübingen, Ain Shams University, Dankook University, Karolinska Institutet, Warszawski Uniwersytet Medyczny, Meiji Seika Pharma, Leids Universitair Medisch Centrum, National and Kapodistrian University of Athens, Shionogi, Universidade Nova de Lisboa, Eskişehir Osmangazi Üniversitesi, Uniwersytet Warszawski, Università degli Studi di Torino, Universidade do Porto, Universidade Federal de Santa Catarina, Université Paris-Saclay, Nanjing Medical University, Universidade Federal de Minas Gerais, Univerza v Ljubljani, Chiba University, Universidade do Minho, Universidad Austral de Chile, Gdański Uniwersytet Medyczny, Centro de Investigação em Tecnologias e Serviços de Saúde, Sorbonne Université, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Metro North Hospital and Health Service, Sanofi-Aventis Deutschland, Canadian Institutes of Health Research, Instituto de Salud Carlos III, Instituto De Saúde Pública, Universidade do Porto, NIH Clinical Center
Openalex Percentile: Top 5%
Allergic Rhinitis and Sensitization
4.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.